Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics
NCT07748364
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Relapsed/Refractory Mantle Cell Lymphoma
Interventions
BIOLOGICAL:
Glofitamab
Sponsor
Joshua Brody
Collaborators
[object Object]